BENIGN PROSTATIC HYPERPLASIA - VIDEO IMAGE-ANALYSIS AND ITS RELATIONSHIP TO ANDROGEN AND EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION

被引:20
作者
FRYDENBERG, M
FOO, TMS
JONES, AS
GRACE, J
HENSLEY, WJ
ROGERS, J
PEARSON, BS
RAGHAVAN, D
机构
[1] ROYAL PRINCE ALFRED HOSP,UROL CANC RES UNIT,SYDNEY,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,DEPT UROL,SYDNEY,AUSTRALIA
[3] ROYAL PRINCE ALFRED HOSP,DEPT ANAT PATHOL & CLIN BIOCHEM,SYDNEY,AUSTRALIA
关键词
PROSTATIC HYPERTROPHY; IMAGE ANALYSIS; ANDROGEN; EPIDERMAL GROWTH FACTOR;
D O I
10.1016/S0022-5347(17)37951-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Androgens are essential for the development and maintenance of the prostate. However, prostatic growth may be mediated by epidermal growth factor (EGF) and the expression of the EGF receptor (EGFR) may be influenced by the androgenic milieu. We have characterized the expression of cytosolic androgen receptor (ARc), nuclear salt extractable androgen receptor (ARn) and EGFR in 89 consecutive cases of benign prostatic hyperplasia, 84 of which were treated by transurethral prostatic resections. Image analysis morphometry was performed on the histological sections to determine the epithelial content of the gland. Our results indicate that there is a vast heterogeneity of receptor expression in benign prostatic hyperplasia. Expression of ARc ranged from zero to 1312 fmol/gm. tissue (mean +/- SD 265 +/- 290), ARn ranged from zero to 531 fmol/gm. tissue (mean +/- SD 145 +/- 98) and EGFR ranged from zero to 316 fmol/gm. tissue (mean +/- SD 121 +/- 76). A statistically significant association was found between expression of ARn and EGFR, and these were both significantly correlated with the epithelial content of the gland.
引用
收藏
页码:872 / 876
页数:5
相关论文
共 38 条
[1]   THE TYPE OF CURRENT FREQUENCY USED IN TRANS-URETHRAL RESECTION OF PROSTATE (TURP) AFFECTS THE ANDROGEN RECEPTOR [J].
ALBERT, J ;
GELLER, J ;
NACHTSHEIM, DA .
PROSTATE, 1982, 3 (03) :221-224
[2]  
BARRACK ER, 1983, CANCER RES, V43, P1107
[3]  
BENSON RC, 1985, CANCER-AM CANCER SOC, V55, P382, DOI 10.1002/1097-0142(19850115)55:2<382::AID-CNCR2820550215>3.0.CO
[4]  
2-2
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   THE USE OF MULTIPLE-VARIABLES TO PREDICT RESPONSE TO ENDOCRINE THERAPY IN CARCINOMA OF THE PROSTATE - A PRELIMINARY-REPORT [J].
BRENDLER, CB ;
ISAACS, JT ;
FOLLANSBEE, AL ;
WALSH, PC .
JOURNAL OF UROLOGY, 1984, 131 (04) :694-700
[8]  
CHAPRONIERE DM, 1986, CANCER RES, V46, P819
[9]  
COHEN S, 1987, IN VITRO CELL DEV B, V23, P239
[10]   SECRETION OF EPIDERMAL GROWTH-FACTOR AND RELATED POLYPEPTIDES BY THE DU-145 HUMAN-PROSTATE CANCER CELL-LINE [J].
CONNOLLY, JM ;
ROSE, DP .
PROSTATE, 1989, 15 (02) :177-186